Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A...

por Jerusalem, Guy, Prat, Aleix, Salgado, Roberto, Reinisch, Mattea, Saura, Cristina, Borrego, Manuel Ruiz, Nikolinakos, Petros, Ades, Felipe, Filian, Jeiry, Huang, Ning, Mazzei-Abba, Antonella, Tolaney, Sara M.
Publicado 2023

The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy

por Gámez-Pozo, Angelo, Pérez Carrión, Ramón M., Manso, Luis, Crespo, Carmen, Mendiola, Cesar, López-Vacas, Rocío, Berges-Soria, Julia, López, Isabel Álvarez, Margeli, Mireia, Calero, Juan L. Bayo, Farre, Xavier González, Santaballa, Ana, Ciruelos, Eva M., Afonso, Ruth, Lao, Juan, Catalán, Gustavo, Gallego, José V. Álvarez, López, José Miramón, Bofill, Francisco J. Salvador, Borrego, Manuel Ruiz, Espinosa, Enrique, Vara, Juan A. Fresno, Zamora, Pilar
Publicado 2014

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy()

por Partridge, Ann H., Niman, Samuel M., Ruggeri, Monica, Peccatori, Fedro A., Azim, Hatem A., Colleoni, Marco, Saura, Cristina, Shimizu, Chikako, Sætersdal, Anna Barbro, Kroep, Judith R., Mailliez, Audrey, Warner, Ellen, Borges, Virginia F., Amant, Frédéric, Gombos, Andrea, Kataoka, Akemi, Rousset-Jablonski, Christine, Borstnar, Simona, Takei, Junko, Lee, Jeong Eon, Walshe, Janice M., Borrego, Manuel Ruíz, Moore, Halle CF., Saunders, Christobel, Cardoso, Fatima, Susnjar, Snezana, Bjelic-Radisic, Vesna, Smith, Karen L., Piccart, Martine, Korde, Larissa A., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia
Publicado 2021